Skip to main content

Journal Club - May 6, 2021


Dr. Nav Malhi presented the RHAPSODY Trial, which is a phase 3, multicenter, double-blind, event-driven, randomized-withdrawal trial of rilonacept in patients with acute symptoms of recurrent pericarditis and systemic inflammation. This trial was published in NEJM in January of this year.

CCI is an inclusive centre with multidisciplinary membership for all cardiovascular investigators in BC